Simvastatin

apolipoprotein B ; Homo sapiens







89 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 9809932 The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease. 1998 Nov 1
52 18370543 Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study. 1998 1
53 9027779 Effect of treatment with simvastatin on serum cholesteryl ester transfer in patients on dialysis. PERFECT Study Collaborative Group. 1997 Jan 2
54 9241623 Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative Group. 1997 Jan-Feb 1
55 9316434 Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects. 1997 Sep 2
56 9476046 Simvastatin reduces activation of normal platelets by LDL isolated from patients with familial hypercholesterolaemia and familial defective apolipoprotein B. 1997 1
57 8620338 Effects of colestipol alone and in combination with simvastatin on apolipoprotein B metabolism. 1996 Feb 1
58 8842455 Differences in hypolipidaemic effects of two statins on Hep G2 cells or human hepatocytes in primary culture. 1996 Aug 1
59 7578166 Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial. 1995 Jul-Aug 1
60 7585842 Effect of low-dose simvastatin on cholesterol levels, oxidative susceptibility, and antioxidant levels of low-density lipoproteins in patients with hypercholesterolemia: a pilot study. 1995 May-Jun 1
61 7589011 Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications. 1995 Aug 1
62 7749833 Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. 1995 Feb 1
63 8187355 Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome. 1994 Mar 2
64 8122478 Efficacy and tolerability of simvastatin 20 mg vs pravastatin 20 mg in patients with primary hypercholesterolemia. European Study Group. 1993 2
65 8240151 Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin. 1993 Aug 2
66 8243858 Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. 1993 Oct 1
67 8264145 Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. 1993 Nov 1
68 8326293 Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study. 1993 Jul 1
69 8427854 Effects of simvastatin on apoB metabolism and LDL subfraction distribution. 1993 Feb 1
70 8487674 Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion. 1993 Apr 1
71 1320552 Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome. 1992 Jun 1
72 1352930 A randomized placebo controlled trial on the effects of simvastatin, a HMG-CoA reductase inhibitor, on blood lipids and fibrinolytic parameters. 1992 1
73 1436290 Effect of simvastatin on qualitative and quantitative changes of lipoprotein metabolism in CAPD patients. 1992 1
74 1495661 Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia. 1992 Jul 22 1
75 1627634 Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes. 1992 Jul 9 1
76 1671145 Poor response to simvastatin in familial defective apo-B-100. 1991 Feb 2 1
77 1777975 Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia. 1991 Dec 16 1
78 1789814 Lipoprotein particle analysis comparing simvastatin and fenofibrate. 1991 Dec 1
79 1987991 Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system. 1991 Jan-Feb 1
80 2051734 Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. 1991 Apr 1
81 2054273 Simvastatin in severe hypercholesterolaemia: a placebo controlled trial. 1991 Mar 2
82 2073672 Safety, tolerability, and efficacy of simvastatin and fenofibrate--a multicenter study. Simvastatin-Fenofibrate Study Group. 1990 1
83 2312032 [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences]. 1990 Feb 10 1
84 2502417 Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia. 1989 1
85 2634479 [Effect of a long-term treatment with simvastatin, an inhibitor of HMG-CoA reductase, in dyslipidemic patients at high risk]. 1989 Dec 1
86 2736571 Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. 1989 Mar-Apr 1
87 2894548 Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia. 1988 Mar 19 2
88 2904053 Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome. 1988 Dec 10 1
89 3234467 Simvastatin and bezafibrate: effects on serum lipoproteins and lecithin: cholesterol acyltransferase activity in familial hypercholesterolaemia. 1988 1